No immunological interference or concerns about safety when seasonal quadrivalent influenza vaccine is co-administered with a COVID-19 mRNA-1273 booster vaccine in adults: A randomized trial

• Главные авторы: Abdi Naficy (Автор), Adrienne Kuxhausen (Автор), Harry Seifert (Автор), Andrew Hastie (Автор), Brett Leav (Автор), Jacqueline Miller (Автор), Kate Anteyi (Автор), Agnes Mwakingwe-Omari (Автор)
• Формат: ‌
• Опубликовано: Taylor & Francis Group, 2024-12-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

ABSTRACTThe objective of the study was to assess the safety and immunogenicity of mRNA-1273 COVID-19 booster vaccination when co-administered with an egg-based standard dose seasonal quadrivalent influenza vaccine (QIV). This was a phase 3, randomized, open-label study. Eligible adults aged ≥ 18 yea...